,Compound_ID,Uniprot_ID,Compound_Name,Standard_inchi_key,Max_Phase,Target_Pref_Name,Gene_Names,Target_Class,Wild_type_or_mutant,Mutation_information,PubMed_ID,standard_type,standard_relation,standard_value,standard_units,Endpoint_Mode_of_Action,Assay_Format,Assay_Type,Assay_Sub_Type,Inhibitor_Type,Detection_Technology,Compound_concentration_value,Compound_concentration_value_units,Substrate_type,Substrate_Type_Standard_Relation,Substrate_Type_Standard_Value,Substrate_Type_Standard_Units,Assay_cell_line,Assay_Description,Activity_Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation_Comments,Assay_ID,DTC_Tid,DTC_Activity_ID,DTC_Molregno,Record_ID,DTC_Document_ID,pDTC_Value,SMILES,base_rdkit_smiles
9,CHEMBL100415,Q12809,,AAXGNXOJOSOUQQ-SANMLTNESA-N,0,HERG,KCNH2,Ion channel,,,11520202.0,IP,=,190.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [35S]MK-499 binding to human ERG potassium channel stably expressed in HEK293 cells,,"Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency.",J. Med. Chem.,2001.0,44.0,18.0,"Bell IM, Gallicchio SN, Abrams M, Beshore DC, Buser CA, Culberson JC, Davide J, Ellis-Hutchings M, Fernandes C, Gibbs JB, Graham SL, Hartman GD, Heimbrook DC, Homnick CF, Huff JR, Kassahun K, Koblan KS, Kohl NE, Lobell RB, Lynch JJ, Miller PA, Omer CA, Rodrigues AD, Walsh ES, Williams TM",,220739.0,DTCT0023241,1173046,DTCC00267778,486561,16375,6.721246399047171,CCCCN(CC1=CN=CN1CC2=CC=C(C=C2)C#N)[C@H]3CCN(C3=O)CC4=CC=CC=C4,CCCCN(Cc1cncn1Cc1ccc(C#N)cc1)[C@H]1CCN(Cc2ccccc2)C1=O
10,CHEMBL100415,Q12809,,AAXGNXOJOSOUQQ-SANMLTNESA-N,0,HERG,KCNH2,Ion channel,,,19534531.0,IC50,=,190.0,NM,,,,,,,,,,,,,,Inhibition of human ERG channel,,Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers.,J. Med. Chem.,2009.0,52.0,14.0,"Zachariae U, Giordanetto F, Leach AG",,545772.0,DTCT0023241,2498475,DTCC00267778,489904,33948,6.721246399047171,CCCCN(CC1=CN=CN1CC2=CC=C(C=C2)C#N)[C@H]3CCN(C3=O)CC4=CC=CC=C4,CCCCN(Cc1cncn1Cc1ccc(C#N)cc1)[C@H]1CCN(Cc2ccccc2)C1=O
162,CHEMBL1080117,Q12809,,AAONJNLMLWRZJE-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,19891474.0,IC50,=,199.53,NM,,,,,,,,,,,,,,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay,,"1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,2010.0,53.0,1.0,"Micheli F, Arista L, Bonanomi G, Blaney FE, Braggio S, Capelli AM, Checchia A, Damiani F, Di-Fabio R, Fontana S, Gentile G, Griffante C, Hamprecht D, Marchioro C, Mugnaini M, Piner J, Ratti E, Tedesco G, Tarsi L, Terreni S, Worby A, Ashby CR, Heidbreder C",,622010.0,DTCT0023241,3231441,DTCC00627324,619242,37839,6.699991797446187,CC1=NC2=CC=CC(=C2C=C1)C3=NN=C(N3C)SCCCN4CC5CC5(C4)C6=CC=C(C=C6)Cl,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)cc5)C4)n3C)cccc2n1
163,CHEMBL1080117,Q12809,,AAONJNLMLWRZJE-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,19891474.0,IC50,=,1584.89,NM,,,,,,,,,,,,,,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay,,"1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,2010.0,53.0,1.0,"Micheli F, Arista L, Bonanomi G, Blaney FE, Braggio S, Capelli AM, Checchia A, Damiani F, Di-Fabio R, Fontana S, Gentile G, Griffante C, Hamprecht D, Marchioro C, Mugnaini M, Piner J, Ratti E, Tedesco G, Tarsi L, Terreni S, Worby A, Ashby CR, Heidbreder C",,622010.0,DTCT0023241,3231329,DTCC00627324,619243,37839,5.800000874803203,CC1=NC2=CC=CC(=C2C=C1)C3=NN=C(N3C)SCCCN4CC5CC5(C4)C6=CC=C(C=C6)Cl,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)cc5)C4)n3C)cccc2n1
164,CHEMBL1080117,Q12809,,AAONJNLMLWRZJE-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,19891474.0,IC50,=,1995.26,NM,,,,,,,,,,,,,,Displacement of [3H]dofetidile from human ERG by scintillation proximity assay,,"1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,2010.0,53.0,1.0,"Micheli F, Arista L, Bonanomi G, Blaney FE, Braggio S, Capelli AM, Checchia A, Damiani F, Di-Fabio R, Fontana S, Gentile G, Griffante C, Hamprecht D, Marchioro C, Mugnaini M, Piner J, Ratti E, Tedesco G, Tarsi L, Terreni S, Worby A, Ashby CR, Heidbreder C",,622010.0,DTCT0023241,3231317,DTCC00627324,619244,37839,5.700000503883016,CC1=NC2=CC=CC(=C2C=C1)C3=NN=C(N3C)SCCCN4CC5CC5(C4)C6=CC=C(C=C6)Cl,Cc1ccc2c(-c3nnc(SCCCN4CC5CC5(c5ccc(Cl)cc5)C4)n3C)cccc2n1
440,CHEMBL1085560,Q12809,,ABCLYDOXFRWKNB-MRXNPFEDSA-N,0,HERG,KCNH2,Ion channel,,,20457525.0,KI,=,2100.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells,,In vitro studies on a class of quinoline containing histamine H3 antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,11.0,"Liu H, Altenbach RJ, Diaz GJ, Manelli AM, Martin RL, Miller TR, Esbenshade TA, Brioni JD, Cowart MD",,634306.0,DTCT0023241,3355768,DTCC00646210,631355,39004,5.6777807052660805,C[C@@H]1CCCN1CCC2=CC3=C(C=C2)N=C(C=C3)C4=C(N=C(C(=C4)C#N)C)C,Cc1nc(C)c(-c2ccc3cc(CCN4CCC[C@H]4C)ccc3n2)cc1C#N
506,CHEMBL1086377,Q12809,KU-0060648,AATCBLYHOUOCTO-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,23855836.0,IC50,>,20000.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human ERG expressed in cisapride treated CHO cells by Ion Works assay,,"1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity.",J. Med. Chem.,2013.0,56.0,16.0,"Cano C, Saravanan K, Bailey C, Bardos J, Curtin NJ, Frigerio M, Golding BT, Hardcastle IR, Hummersone MG, Menear KA, Newell DR, Richardson CJ, Shea K, Smith GC, Thommes P, Ting A, Griffin RJ",,978839.0,DTCT0023241,12553458,DTCC00031196,1062222,55712,4.698970004336019,CCN1CCN(CC1)CC(=O)NC2=C3C4=CC=CC=C4SC3=C(C=C2)C5=CC=CC6=C5OC(=CC6=O)N7CCOCC7,CCN1CCN(CC(=O)Nc2ccc(-c3cccc4c(=O)cc(N5CCOCC5)oc34)c3sc4ccccc4c23)CC1
640,CHEMBL1090526,Q12809,,ABDWUBPDHWDFCV-CYBMUJFWSA-N,0,HERG,KCNH2,Ion channel,,,20227880.0,IC50,=,1800.0,NM,,,,,,,,,,,,,,Inhibition of human ERG by patch clamp assay,,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,2010.0,20.0,8.0,"Li BF, Moree WJ, Yu J, Coon T, Zamani-Kord S, Malany S, Jalali K, Wen J, Wang H, Yang C, Hoare SR, Petroski RE, Madan A, Crowe PD, Beaton G",,625165.0,DTCT0023241,3285132,DTCC00636074,1265609,38338,5.7447274948966935,C[C@H](C1=C(CC2=C1C=CC(=C2)F)CCN(C)C)C3=NC=CN=C3OC,COc1nccnc1[C@H](C)C1=C(CCN(C)C)Cc2cc(F)ccc21
641,CHEMBL1090526,Q12809,,ABDWUBPDHWDFCV-CYBMUJFWSA-N,0,HERG,KCNH2,Ion channel,,,20227880.0,KI,>,3000.0,NM,,,,,,,,,,,,,,Displacement of dofetilide from human ERG,,Selectivity profiling of novel indene H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,2010.0,20.0,8.0,"Li BF, Moree WJ, Yu J, Coon T, Zamani-Kord S, Malany S, Jalali K, Wen J, Wang H, Yang C, Hoare SR, Petroski RE, Madan A, Crowe PD, Beaton G",,625166.0,DTCT0023241,3285140,DTCC00636074,1265609,38338,5.522878745280337,C[C@H](C1=C(CC2=C1C=CC(=C2)F)CCN(C)C)C3=NC=CN=C3OC,COc1nccnc1[C@H](C)C1=C(CCN(C)C)Cc2cc(F)ccc21
777,CHEMBL1092748,Q12809,,ABOSMIZKCHEJEN-KIKDMBQDSA-N,0,HERG,KCNH2,Ion channel,,,20346664.0,IC50,=,4000.0,NM,,,,,,,,,,,,,,Inhibition of human ERG by FLIPR assay,,gamma-Lactams as glycinamide replacements in cyclohexane-based CC chemokine receptor 2 (CCR2) antagonists.,Bioorg. Med. Chem. Lett.,2010.0,20.0,8.0,"Cherney RJ, Mo R, Meyer DT, Voss ME, Yang MG, Santella JB, Duncia JV, Lo YC, Yang G, Miller PB, Scherle PA, Zhao Q, Mandlekar S, Cvijic ME, Barrish JC, Decicco CP, Carter PH",,625756.0,DTCT0023241,3274329,DTCC00638622,1375410,38472,5.3979400086720375,CC(C)N(C)[C@@H]1CC[C@@H]([C@@H](C1)CS(=O)(=O)C2=CC=CC=C2)N3CC[C@@H](C3=O)NC(=O)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,CC(C)N(C)[C@@H]1CC[C@H](N2CC[C@H](NC(=O)c3cc(C(F)(F)F)cc(C(F)(F)F)c3)C2=O)[C@H](CS(=O)(=O)c2ccccc2)C1
1299,CHEMBL12,Q12809,DIAZEPAM,AAOVKJBEBIDNHE-UHFFFAOYSA-N,4,HERG,KCNH2,Ion channel,,,,IC50,,,,,,,,,,,,,,,,HEK293,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774669.0,DTCT0023241,7363786,DTCC00132806,51463,46191,,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
1300,CHEMBL12,Q12809,DIAZEPAM,AAOVKJBEBIDNHE-UHFFFAOYSA-N,4,HERG,KCNH2,Ion channel,,,,KI,,,,,,,,,,,,,,,,HEK293,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774669.0,DTCT0023241,7363787,DTCC00132806,51463,46191,,CN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3,CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21
1881,CHEMBL1256865,Q12809,GR-89696,ABTNETSDXZBJTE-WLHGVMLRSA-N,0,HERG,KCNH2,Ion channel,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,752583.0,DTCT0023241,6706895,DTCC00032422,1089155,33038,4.949999401714238,COC(=O)N1CCN(C(C1)CN2CCCC2)C(=O)CC3=CC(=C(C=C3)Cl)Cl.C(=C/C(=O)O)\C(=O)O,COC(=O)N1CCN(C(=O)Cc2ccc(Cl)c(Cl)c2)C(CN2CCCC2)C1
2002,CHEMBL1258904,Q12809,,AAJMQTLFRTZCJK-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,25079952.0,INHIBITION,=,26.0,%,,cell_based,,,,,,,,,,,,Inhibition of human ERG expressed in HEK-293 cells at 50 uM by whole-cell patch-clamp technique,,Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy.,J. Med. Chem.,2014.0,57.0,16.0,"Lee KS, Liu JY, Wagner KM, Pakhomova S, Dong H, Morisseau C, Fu SH, Yang J, Wang P, Ulu A, Mate CA, Nguyen LV, Hwang SH, Edin ML, Mara AA, Wulff H, Newcomer ME, Zeldin DC, Hammock BD",,1456714.0,DTCT0023241,13900568,DTCC00702063,461155,61104,26.0,CCC(=O)N1CCC(CC1)NC(=O)NC2=CC=C(C=C2)OC(F)(F)F,CCC(=O)N1CCC(NC(=O)Nc2ccc(OC(F)(F)F)cc2)CC1
2748,CHEMBL1499488,Q12809,,AAFXQFIGKBLKMC-KQQUZDAGSA-N,0,HERG,KCNH2,Ion channel,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity. (Class of assay: confirmatory) ,inconclusive,PUBCHEM BIOASSAY DATA SET,,,,,,,752583.0,DTCT0023241,6706888,DTCC00897156,1758647,33038,4.100000128334196,C1=CC(=CC=C1/C=C/C(=O)O)/C=C/C(=O)O,O=C(O)/C=C/c1ccc(/C=C/C(=O)O)cc1
3089,CHEMBL1642190,Q12809,,ABUSVPPSVYCGDS-WYMLVPIESA-N,0,HERG,KCNH2,Ion channel,,,21190851.0,IC50,=,1120.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of radiolabeled MK-499 from human ERG expressed in HEK293 cells,,Quinazolinones as ¿-secretase modulators.,Bioorg. Med. Chem. Lett.,2011.0,21.0,2.0,"Fischer C, Shah S, Hughes BL, Nikov GN, Crispino JL, Middleton RE, Szewczak AA, Munoz B, Shearman MS",,699709.0,DTCT0023241,5031868,DTCC01018963,2038508,42443,5.950781977329818,CC1=CN(C=N1)C2=C(C=C(C=C2)/C=C/C3=NC(=C4C5=C(CCC5)SC4=N3)NCC6=CC=CC=C6)OC,COc1cc(/C=C/c2nc(NCc3ccccc3)c3c4c(sc3n2)CCC4)ccc1-n1cnc(C)c1
4255,CHEMBL1822863,Q12809,,ABCLYDOXFRWKNB-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,21802950.0,IC50,=,8400.0,NM,,,,,,,,,,,,,,Displacement of [3H]dofetilide from human recombinant ERG by Competitive binding assay,,Novel and highly potent histamine H3 receptor ligands. Part 1: withdrawing of hERG activity.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Levoin N, Labeeuw O, Calmels T, Poupardin-Olivier O, Berrebi-Bertrand I, Lecomte JM, Schwartz JC, Capet M",,766668.0,DTCT0023241,6082153,DTCC01104761,329311,45781,5.075720713938118,CC1CCCN1CCC2=CC3=C(C=C2)N=C(C=C3)C4=C(N=C(C(=C4)C#N)C)C,Cc1nc(C)c(-c2ccc3cc(CCN4CCCC4C)ccc3n2)cc1C#N
4801,CHEMBL1916011,Q12809,,ABHOXTZUEJOESC-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,21924614.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human ERG,Active,Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: Identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds.,Bioorg. Med. Chem. Lett.,2011.0,21.0,21.0,"Meyers MJ, Long SA, Pelc MJ, Wang JL, Bowen SJ, Walker MC, Schweitzer BA, Madsen HM, Tenbrink RE, McDonald J, Smith SE, Foltin S, Beidler D, Thorarensen A",,787814.0,DTCT0023241,7524583,DTCC00129087,1351167,46365,,C1CN(CCC12CC(C2)C3=CC(=CC=C3)OC4=NC=C(C=C4)C(F)(F)F)C(=O)NC5=NN=CC=C5,O=C(Nc1cccnn1)N1CCC2(CC1)CC(c1cccc(Oc3ccc(C(F)(F)F)cn3)c1)C2
5434,CHEMBL2012042,Q12809,,ABYINJFKAFRKKD-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,22306122.0,INHIBITION,=,48.0,%,,,,,,,,,,,,,,Displacement of dofetilide from human ERG at 30 uM,,"The discovery of aminopyrazines as novel, potent Na(v)1.7 antagonists: hit-to-lead identification and SAR.",Bioorg. Med. Chem. Lett.,2012.0,22.0,5.0,"Bregman H, Nguyen HN, Feric E, Ligutti J, Liu D, McDermott JS, Wilenkin B, Zou A, Huang L, Li X, McDonough SI, Dimauro EF",,811995.0,DTCT0023241,10420842,DTCC01226476,963418,47698,48.0,C1CC1C2=CC=C(C=C2)OC3=CC=C(C=C3)NC4=NC(=CN=C4)N,Nc1cncc(Nc2ccc(Oc3ccc(C4CC4)cc3)cc2)n1
6191,CHEMBL205720,Q12809,,AATPBSGADBLKLD-JAFNVKOHSA-N,0,HERG,KCNH2,Ion channel,,,16337121.0,INHIBITION,=,70.0,%,,,,,,,,,,,,,,Displacement of [35S]-labeled MK499 from hERG at 10 uM,,"Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers.",Bioorg. Med. Chem. Lett.,2006.0,16.0,5.0,"Ok D, Li C, Abbadie C, Felix JP, Fisher MH, Garcia ML, Kaczorowski GJ, Lyons KA, Martin WJ, Priest BT, Smith MM, Williams BS, Wyvratt MJ, Parsons WH",,337840.0,DTCT0023241,1905446,DTCC00417063,1081327,20445,70.0,C1C[C@H]([C@@H](C1)OCCC2=CC=C(C=C2)OC(F)(F)F)C(CCC3=CC=CC=C3)O,OC(CCc1ccccc1)[C@@H]1CCC[C@H]1OCCc1ccc(OC(F)(F)F)cc1
6226,CHEMBL2059319,Q12809,,ABUDXXYFKLCSKO-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,22677319.0,IC50,=,5700.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human ERG expressed in CHO cells after 30 mins by Rb+ flux assay,,Hit-to-lead investigation of a series of novel combined dopamine D2 and muscarinic M1 receptor ligands with putative antipsychotic and pro-cognitive potential.,Bioorg. Med. Chem. Lett.,2012.0,22.0,15.0,"Sams AG, Larsen K, Mikkelsen GK, Hentzer M, Christoffersen CT, Jensen KG, Frederiksen K, Bang-Andersen B",,829290.0,DTCT0023241,10536803,DTCC01246262,415169,48886,5.2441251443275085,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCN4C(=O)CCC5=C4C=C(C=C5)F,O=C1CCc2ccc(F)cc2N1CCCN1CCC(n2c(=O)[nH]c3ccccc32)CC1
6812,CHEMBL2158292,Q12809,,AADUJBXZMSDOOW-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,22039836.0,IC50,,,,,,,,,,,,,,,,,Displacement of [3H]astemizole from human ERG potassium channel,Not Determined,Optimization of a potent class of arylamide colony-stimulating factor-1 receptor inhibitors leading to anti-inflammatory clinical candidate 4-cyano-N-[2-(1-cyclohexen-1-yl)-4-[1-[(dimethylamino)acetyl]-4-piperidinyl]phenyl]-1H-imidazole-2-carboxamide (JNJ-28312141).,J. Med. Chem.,2011.0,54.0,22.0,"Illig CR, Manthey CL, Wall MJ, Meegalla SK, Chen J, Wilson KJ, Ballentine SK, Desjarlais RL, Schubert C, Crysler CS, Chen Y, Molloy CJ, Chaikin MA, Donatelli RR, Yurkow E, Zhou Z, Player MR, Tomczuk BE",,857323.0,DTCT0023241,11382020,DTCC01286989,770195,51014,,C1CCC(=CC1)C2=C(C=CC(=C2)C3CCN(CC3)C(=O)C4=CC=[N+](C=C4)[O-])NC(=O)C5=NC=C(N5)C#N,N#Cc1cnc(C(=O)Nc2ccc(C3CCN(C(=O)c4cc[n+]([O-])cc4)CC3)cc2C2=CCCCC2)[nH]1
6829,CHEMBL2158563,Q12809,,ABQRRZZEGCBSBT-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,23018093.0,IC50,=,3140.0,NM,,,,,,,,,,,,,,Displacement of [3H]-dofetilide from human ERG,,"Targeting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization.",Bioorg. Med. Chem.,2012.0,20.0,22.0,"Davies NG, Browne H, Davis B, Drysdale MJ, Foloppe N, Geoffrey S, Gibbons B, Hart T, Hubbard R, Jensen MR, Mansell H, Massey A, Matassova N, Moore JD, Murray J, Pratt R, Ray S, Robertson A, Roughley SD, Schoepfer J, Scriven K, Simmonite H, Stokes S, Surgenor A, Webb P, Wood M, Wright L, Brough P",,856088.0,DTCT0023241,11382271,DTCC01287263,653657,51081,5.503070351926785,CCN(CC)CCOC1=C(C=C(C(=C1)C2=C3C(=CNC3=NC(=N2)SCC(=O)NC)C#N)Cl)Cl,CCN(CC)CCOc1cc(-c2nc(SCC(=O)NC)nc3[nH]cc(C#N)c23)c(Cl)cc1Cl
6830,CHEMBL2158563,Q12809,,ABQRRZZEGCBSBT-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,23018093.0,IC50,=,17800.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human ERG expressed in HEK293 cells by voltage-clamp method,,"Targeting conserved water molecules: Design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization.",Bioorg. Med. Chem.,2012.0,20.0,22.0,"Davies NG, Browne H, Davis B, Drysdale MJ, Foloppe N, Geoffrey S, Gibbons B, Hart T, Hubbard R, Jensen MR, Mansell H, Massey A, Matassova N, Moore JD, Murray J, Pratt R, Ray S, Robertson A, Roughley SD, Schoepfer J, Scriven K, Simmonite H, Stokes S, Surgenor A, Webb P, Wood M, Wright L, Brough P",,856089.0,DTCT0023241,11382190,DTCC01287263,653657,51081,4.749579997691106,CCN(CC)CCOC1=C(C=C(C(=C1)C2=C3C(=CNC3=NC(=N2)SCC(=O)NC)C#N)Cl)Cl,CCN(CC)CCOc1cc(-c2nc(SCC(=O)NC)nc3[nH]cc(C#N)c23)c(Cl)cc1Cl
7487,CHEMBL2203618,Q12809,,ABQNQYIWXKWYGD-CAQDGQBVSA-N,0,HERG,KCNH2,Ion channel,,,16629828.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human ERG,Active,The discovery of tropane-derived CCR5 receptor antagonists.,Chem. Biol. Drug Des.,2006.0,67.0,4.0,"Armour DR, de Groot MJ, Price DA, Stammen BL, Wood A, Perros M, Burt C",,879195.0,DTCT0023241,11478939,DTCC01299008,847834,51824,,CC1=NC2=CC=CC=C2N1C3[C@H]4[C@@H]3CN(C4)CC[C@@H](C5=CC=CC=C5)NC(=O)C6CCC6,Cc1nc2ccccc2n1C1[C@@H]2CN(CC[C@H](NC(=O)C3CCC3)c3ccccc3)C[C@H]12
7645,CHEMBL2207429,Q12809,,AASJEUHBEWXQIG-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,23153798.0,INHIBITION,=,31.0,%,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]dofetilide from human ERG expressed in HEK293 cells at 10 uM,,Identification of novel series of pyrazole and indole-urea based DFG-out PYK2 inhibitors.,Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Bhattacharya SK, Aspnes GE, Bagley SW, Boehm M, Brosius AD, Buckbinder L, Chang JS, Dibrino J, Eng H, Frederick KS, Griffith DA, Griffor MC, Guimarães CR, Guzman-Perez A, Han S, Kalgutkar AS, Klug-McLeod J, Garcia-Irizarry C, Li J, Lippa B, Price DA, Southers JA, Walker DP, Wei L, Xiao J, Zawistoski MP, Zhao X",,885495.0,DTCT0023241,11488962,DTCC01302606,1418019,52177,31.0,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=CC4=C3NC(=C4)C(=O)N(C)CCC5=CC=CC=N5,Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3cc(C(=O)N(C)CCc4ccccn4)[nH]c23)cc1
8527,CHEMBL235842,Q12809,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,18182289.0,ACTIVITY,>,30000.0,NM,,,,,,,,,,,,,,Inhibition of human ERG,,Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2).,Bioorg. Med. Chem. Lett.,2008.0,18.0,3.0,"Methot JL, Chakravarty PK, Chenard M, Close J, Cruz JC, Dahlberg WK, Fleming J, Hamblett CL, Hamill JE, Harrington P, Harsch A, Heidebrecht R, Hughes B, Jung J, Kenific CM, Kral AM, Meinke PT, Middleton RE, Ozerova N, Sloman DL, Stanton MG, Szewczak AA, Tyagarajan S, Witter DJ, Secrist JP, Miller TA",,468846.0,DTCT0023241,2302701,DTCC00467489,1728853,25665,4.522878745280337,CC(=O)NC1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)C3=CC=CS3)N,CC(=O)Nc1ccc(C(=O)Nc2cc(-c3cccs3)ccc2N)cc1
8832,CHEMBL2407175,Q12809,,AATNRUXRJQIOEV-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,23816371.0,IC50,=,670.0,NM,,,,,,,,,,,,,,Inhibition of human ERG by automated planar patch-clamp system,,Identification of N-substituted 8-azatetrahydroquinolone derivatives as selective and orally active M1 and M4 muscarinic acetylcholine receptors agonists.,Bioorg. Med. Chem. Lett.,2013.0,23.0,16.0,"Takai K, Inoue Y, Konishi Y, Suwa A, Uruno Y, Matsuda H, Nakako T, Sakai M, Nishikawa H, Hashimoto G, Enomoto T, Kitamura A, Uematsu Y, Kiyoshi A, Sumiyoshi T",,973733.0,DTCT0023241,12518187,DTCC01385574,1009659,55302,6.173925197299173,CCCN1C(=O)CC2(CCN(CC2)CC3CCN(CC3)C(=O)OCC)C4=C1N=CC=C4,CCCN1C(=O)CC2(CCN(CC3CCN(C(=O)OCC)CC3)CC2)c2cccnc21
9096,CHEMBL2440382,Q12809,,ABPDDHUOGSTTQN-VULFUBBASA-N,0,HERG,KCNH2,Ion channel,,,24071446.0,IC50,,,,,cell_based,,,,,,,,,,,CHO,Inhibition of human ERG channel expressed in CHO cells by whole cell patch clamp technique,Not Determined,Design and bio-evaluation of indole derivatives as potent Kv1.5 inhibitors.,Bioorg. Med. Chem.,2013.0,21.0,21.0,"Guo X, Yang Q, Xu J, Zhang L, Chu H, Yu P, Zhu Y, Wei J, Chen W, Zhang Y, Zhang X, Sun H, Tang Y, You Q",,990152.0,DTCT0023241,12628776,DTCC01400745,1768818,56257,,CC1=CC=C(C=C1)S(=O)(=O)N/N=C/C2=CN(C3=CC=CC=C32)CC(=O)NC4=CC=C(C=C4)Cl,Cc1ccc(S(=O)(=O)N/N=C/c2cn(CC(=O)Nc3ccc(Cl)cc3)c3ccccc23)cc1
9177,CHEMBL2441440,Q12809,,AAYRYIFNKRSGOF-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,24075732.0,IC50,=,2500.0,NM,,,,,,,,,,,,,,Displacement of [35S]-MK499 from human ERG,,Discovery of a novel sub-class of ROMK channel inhibitors typified by 5-(2-(4-(2-(4-(1H-Tetrazol-1-yl)phenyl)acetyl)piperazin-1-yl)ethyl)isobenzofuran-1(3H)-one.,Bioorg. Med. Chem. Lett.,2013.0,23.0,21.0,"Tang H, de Jesus RK, Walsh SP, Zhu Y, Yan Y, Priest BT, Swensen AM, Alonso-Galicia M, Felix JP, Brochu RM, Bailey T, Thomas-Fowlkes B, Zhou X, Pai LY, Hampton C, Hernandez M, Owens K, Roy S, Kaczorowski GJ, Yang L, Garcia ML, Pasternak A",,990660.0,DTCT0023241,12637728,DTCC01401809,1398824,56271,5.6020599913279625,C1CN(CCN1CCC2=CC3=C(COC3)C=C2)C(=O)CC4=CC=C(C=C4)N5C=NN=N5,O=C(Cc1ccc(-n2cnnn2)cc1)N1CCN(CCc2ccc3c(c2)COC3)CC1
9516,CHEMBL256659,Q12809,,ABWRXTVIPWIMTE-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,18178090.0,IC50,=,5011.87,NM,,,,,,,,,,,,,,Inhibition of human ERG,,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.,Bioorg. Med. Chem. Lett.,2008.0,18.0,3.0,"Micheli F, Bonanomi G, Braggio S, Capelli AM, Damiani F, Di Fabio R, Donati D, Gentile G, Hamprecht D, Perini O, Petrone M, Tedesco G, Terreni S, Worby A, Heidbreder C",,468579.0,DTCT0023241,2302227,DTCC00500123,148232,25638,5.300000202445418,CC1=C(OC=N1)C2=NN=C(N2C)SCCCN3CCC4=C(CC3)C5=C(C=C4)N=C(O5)C(F)(F)F,Cc1ncoc1-c1nnc(SCCCN2CCc3ccc4nc(C(F)(F)F)oc4c3CC2)n1C
9579,CHEMBL261176,Q12809,,ABOTXPKVARXPFD-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,18307293.0,IC50,,,,,cell_based,,,,,,,,,,,HEK293,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique,Not Determined,"2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationships.",J. Med. Chem.,2008.0,51.0,6.0,"Slee DH, Moorjani M, Zhang X, Lin E, Lanier MC, Chen Y, Rueter JK, Lechner SM, Markison S, Malany S, Joswig T, Santos M, Gross RS, Williams JP, Castro-Palomino JC, Crespo MI, Prat M, Gual S, Díaz JL, Jalali K, Sai Y, Zuo Z, Yang C, Wen J, O'Brien Z, Petroski R, Saunders J",,465697.0,DTCT0023241,2321263,DTCC00503619,1182717,25415,,CC1=CC=C(O1)C2=NC(=CC(=N2)N3C(=CC(=N3)C)C)NC(=O)CN4CCOCC4,Cc1cc(C)n(-c2cc(NC(=O)CN3CCOCC3)nc(-c3ccc(C)o3)n2)n1
9619,CHEMBL268868,Q12809,DAPH,AAALVYBICLMAMA-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity. (Class of assay: confirmatory) ,active,PUBCHEM BIOASSAY DATA SET,,,,,,,752583.0,DTCT0023241,6710828,DTCC00134512,1922493,33038,4.899998417198648,C1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=CC=C4,O=C1NC(=O)c2cc(Nc3ccccc3)c(Nc3ccccc3)cc21
9652,CHEMBL270853,Q12809,,ABOWDNIHZHLENL-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,18248991.0,IC50,=,31622.78,NM,,,,,,,,,,,,,,Displacement of [3H]Dofetilide from human ERG,,New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.,Bioorg. Med. Chem. Lett.,2008.0,18.0,3.0,"Micheli F, Bonanomi G, Braggio S, Capelli AM, Celestini P, Damiani F, Di Fabio R, Donati D, Gagliardi S, Gentile G, Hamprecht D, Petrone M, Radaelli S, Tedesco G, Terreni S, Worby A, Heidbreder C",,465006.0,DTCT0023241,2310211,DTCC00500026,1103136,25355,4.499999953328896,CC1=NC2=CC=CC(=C2C=C1)C3=NN=C(N3C)SCCCCN4CCC5=CC6=C(C=C5CC4)C(=O)N(C6)C,Cc1ccc2c(-c3nnc(SCCCCN4CCc5cc6c(cc5CC4)C(=O)N(C)C6)n3C)cccc2n1
9985,CHEMBL3086040,Q12809,,ABJSOROVZZKJGI-OCYUSGCXSA-N,0,HERG,KCNH2,Ion channel,,,24157366.0,IC50,=,590.0,NM,,,,,,,,,,,,,,Inhibition of human ERG,,Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors.,Bioorg. Med. Chem. Lett.,2013.0,23.0,23.0,"Debenham JS, Graham TH, Verras A, Zhang Y, Clements MJ, Kuethe JT, Madsen-Duggan C, Liu W, Bhatt UR, Chen D, Chen Q, Garcia-Calvo M, Geissler WM, He H, Li X, Lisnock J, Shen Z, Tong X, Tung EC, Wiltsie J, Xu S, Hale JJ, Pinto S, Shen DM",,1275519.0,DTCT0023241,12943461,DTCC01408766,706930,56424,6.229147988357856,C1C[C@H]([C@@H](C[C@@H]1N2CCOCC2)C3=CC=C(C=C3)Br)C(=O)NC(C4=CC=C(C=C4)Cl)C5=CC(=NC=C5)F,O=C(NC(c1ccc(Cl)cc1)c1ccnc(F)c1)[C@@H]1CC[C@@H](N2CCOCC2)C[C@H]1c1ccc(Br)cc1
10189,CHEMBL3115111,Q12809,,ABHVKYFWPPHTHF-ZMSNHJSUSA-N,0,HERG,KCNH2,Ion channel,,,23916257.0,IC50,>,50000.0,NM,,,,,,,,,,,,,,Binding affinity to human ERG,,Discovery and SAR of 5-aminooctahydrocyclopentapyrrole-3a-carboxamides as potent CCR2 antagonists.,Bioorg. Med. Chem. Lett.,2014.0,24.0,4.0,"Cai C, McComsey DF, Hou C, O'Neill JC, Opas E, McKenney S, Johnson D, Sui Z",,1290262.0,DTCT0023241,13021350,DTCC01423159,1769047,57082,4.301029995663981,COC1COCCC1N[C@@H]2C[C@H]3CN(C[C@]3(C2)C(=O)N4CCC5=C(C4)C=C(C=N5)C(F)(F)F)C(=O)OCCN6CCOCC6,COC1COCCC1N[C@@H]1C[C@H]2CN(C(=O)OCCN3CCOCC3)C[C@@]2(C(=O)N2CCc3ncc(C(F)(F)F)cc3C2)C1
10431,CHEMBL3216119,Q12809,,AAOAGEBZCSUMBQ-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,22335555.0,EC50,=,4500.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human ERG expressed in HEK293 cells at -80 mV holding potential assessed as reduction in tail current amplitude by conventional patch clamp assay,,"1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate.",J. Med. Chem.,2012.0,55.0,6.0,"Ramnauth J, Renton P, Dove P, Annedi SC, Speed J, Silverman S, Mladenova G, Maddaford SP, Zinghini S, Rakhit S, Andrews J, Lee DK, Zhang D, Porreca F",,859035.0,DTCT0023241,11392661,DTCC01463535,1300089,51191,5.346787486224656,CCN(C)CCN1CCCC2=C1C=CC(=C2)N=C(C3=CC=CS3)N.Cl.Cl,CCN(C)CCN1CCCc2cc(N=C(N)c3cccs3)ccc21
10587,CHEMBL3221489,Q12809,,AAGISEXHOPCAHZ-KRWDZBQOSA-N,0,HERG,KCNH2,Ion channel,,,,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of human ERG,,,MedChemComm,2013.0,4.0,4.0,,,1328159.0,DTCT0023241,13593283,DTCC01468420,869645,40542,4.0,CC1=CN=C(C=C1)NC(=O)[C@H](COC(C)C)OC2=NC=NC3=C2C=NN3C4=C(C=CC=N4)Cl,Cc1ccc(NC(=O)[C@H](COC(C)C)Oc2ncnc3c2cnn3-c2ncccc2Cl)nc1
10730,CHEMBL3262143,Q12809,,ABWJEIIFONCFKT-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,24814197.0,INHIBITION,=,19.0,%,,,,,,,,,,,,,,Inhibition of human ERG at 1 uM by whole-cell voltage clamp assay,,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,2014.0,57.0,10.0,"Clark RB, Lamppu D, Libertine L, McDonough A, Kumar A, LaRosa G, Rush R, Elbaum D",,1348020.0,DTCT0023241,13710420,DTCC01487587,1159462,58852,19.0,C1CN(C(CN1)COC2=CN=CC=C2)C3=NC4=C(C=CC=C4S3)F.Cl,Fc1cccc2sc(N3CCNCC3COc3cccnc3)nc12
11387,CHEMBL3355577,Q12809,,AAKMJUPOUGDBIB-OSPTYYIOSA-N,0,HERG,KCNH2,Ion channel,,,25155913.0,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of human ERG by cell-based patch clamp method,Not Determined,Optimization of physicochemical properties and safety profile of novel bacterial topoisomerase type II inhibitors (NBTIs) with activity against Pseudomonas aeruginosa.,Bioorg. Med. Chem.,2014.0,22.0,19.0,"Reck F, Ehmann DE, Dougherty TJ, Newman JV, Hopkins S, Stone G, Agrawal N, Ciaccio P, McNulty J, Barthlow H, O'Donnell J, Goteti K, Breen J, Comita-Prevoir J, Cornebise M, Cronin M, Eyermann CJ, Geng B, Carr GR, Pandarinathan L, Tang X, Cottone A, Zhao L, Bezdenejnih-Snyder N",,1453433.0,DTCT0023241,13949286,DTCC01533014,429818,59769,,CNC(CN1C2=CC(=C(C=C2N=CC1=O)F)OC)C3CCC(CC3)NCC4=NC=C5C(=N4)NC(=O)CO5,CNC(Cn1c(=O)cnc2cc(F)c(OC)cc21)C1CCC(NCc2ncc3c(n2)NC(=O)CO3)CC1
12094,CHEMBL3577956,Q12809,,ABJWJGMTLYSISP-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,25893048.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-astemizole from human ERG expressed in HEK293 cells after 60 mins by scintillation counting analysis,,,ACS Med. Chem. Lett.,2015.0,6.0,4.0,,,1496467.0,DTCT0023241,14434390,DTCC01646032,386606,62611,5.0,C1CC(C1)N2CCN(CC2)C(=O)C3=CC=C(C=C3)CN4CCOCC4,O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CCC2)CC1
12647,CHEMBL3609637,Q12809,,AAHNBILIYONQLX-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,26212776.0,IC50,=,2610.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human ERG expressed in HEK cells by MK-499 radioligand displacement assay,,Discovery of novel triazolobenzazepinones as ¿-secretase modulators with central Aß42 lowering in rodents and rhesus monkeys.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Fischer C, Zultanski SL, Zhou H, Methot JL, Shah S, Hayashi I, Hughes BL, Moxham CM, Bays NW, Smotrov N, Hill AD, Pan BS, Wu Z, Moy LY, Tanga F, Kenific C, Cruz JC, Walker D, Bouthillette M, Nikov GN, Deshmukh SV, Jeliazkova-Mecheva VV, Diaz D, Michener MS, Cook JJ, Munoz B, Shearman MS",,1512245.0,DTCT0023241,14521550,DTCC01660254,1130141,63444,5.583359492661719,CC1=CN(C=N1)C2=C(C=C(C=C2)C3=CN(N=N3)C4CCC5=C(C=CC=C5F)N(C4=O)CC(F)(F)F)OC,COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1
12648,CHEMBL3609637,Q12809,,AAHNBILIYONQLX-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,26212776.0,IC50,=,12900.0,NM,,cell_based,,,,,,,,,,,,Inhibition of human ERG expressed in HEK cells assessed as reduction in IKr current by patchXpress assay,,Discovery of novel triazolobenzazepinones as ¿-secretase modulators with central Aß42 lowering in rodents and rhesus monkeys.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Fischer C, Zultanski SL, Zhou H, Methot JL, Shah S, Hayashi I, Hughes BL, Moxham CM, Bays NW, Smotrov N, Hill AD, Pan BS, Wu Z, Moy LY, Tanga F, Kenific C, Cruz JC, Walker D, Bouthillette M, Nikov GN, Deshmukh SV, Jeliazkova-Mecheva VV, Diaz D, Michener MS, Cook JJ, Munoz B, Shearman MS",,1512238.0,DTCT0023241,14521585,DTCC01660254,1130141,63444,4.889410289700751,CC1=CN(C=N1)C2=C(C=C(C=C2)C3=CN(N=N3)C4CCC5=C(C=CC=C5F)N(C4=O)CC(F)(F)F)OC,COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1
12654,CHEMBL3609749,Q12809,,AAHNBILIYONQLX-QFIPXVFZSA-N,0,HERG,KCNH2,Ion channel,,,26142947.0,EC50,=,13000.0,NM,,cell_based,,,,,,,,,,,,Inhibition of human ERG expressed in CHO cells by patch clamp assay,,Potent benzoazepinone ¿-secretase modulators with improved bioavailability.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Methot JL, Fischer C, Li C, Rivkin A, Ahearn SP, Brown WC, Kattar S, Kelley E, Mampreian DM, Schell A, Rosenau A, Zhou H, Ball R, Deshmukh SV, Jeliazkova-Mecheva VV, Diaz D, Moy LY, Kenific CM, Moxham C, Shah S, Nuthall H, Szewczak AA, Hill A, Hughes B, Smotrov N, Munoz B, Miller TA, Shearman MS",,1512332.0,DTCT0023241,14522917,DTCC01660367,689484,63410,4.886056647693163,CC1=CN(C=N1)C2=C(C=C(C=C2)C3=CN(N=N3)[C@H]4CCC5=C(C=CC=C5F)N(C4=O)CC(F)(F)F)OC,COc1cc(-c2cn([C@H]3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1
12655,CHEMBL3609749,Q12809,,AAHNBILIYONQLX-QFIPXVFZSA-N,0,HERG,KCNH2,Ion channel,,,26142947.0,KI,=,2900.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human ERG expressed in HEK293 cells by radioligand displacement assay,,Potent benzoazepinone ¿-secretase modulators with improved bioavailability.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Methot JL, Fischer C, Li C, Rivkin A, Ahearn SP, Brown WC, Kattar S, Kelley E, Mampreian DM, Schell A, Rosenau A, Zhou H, Ball R, Deshmukh SV, Jeliazkova-Mecheva VV, Diaz D, Moy LY, Kenific CM, Moxham C, Shah S, Nuthall H, Szewczak AA, Hill A, Hughes B, Smotrov N, Munoz B, Miller TA, Shearman MS",,1512331.0,DTCT0023241,14522909,DTCC01660367,689484,63410,5.5376020021010435,CC1=CN(C=N1)C2=C(C=C(C=C2)C3=CN(N=N3)[C@H]4CCC5=C(C=CC=C5F)N(C4=O)CC(F)(F)F)OC,COc1cc(-c2cn([C@H]3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1
12672,CHEMBL3612799,Q12809,,ABQYVJPTPMJTBN-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,26191360.0,IC50,=,9000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [35S]-MK499 from human ERG expressed in HEK293 cells,,,ACS Med. Chem. Lett.,2015.0,6.0,7.0,,,1515502.0,DTCT0023241,14524676,DTCC01661248,1161412,63523,5.045757490560675,CC1=C(C=CC2=C1COC2=O)C(CN3CCN(CC3)CCC4=CC(=C(C=C4)C#N)OC)O,COc1cc(CCN2CCN(CC(O)c3ccc4c(c3C)COC4=O)CC2)ccc1C#N
14242,CHEMBL410234,Q12809,,AACWUFIIMOHGSO-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,18307293.0,IC50,=,650.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human ERG potassium current expressed in HEK293 cells by patch-clamp technique,,"2-Amino-N-pyrimidin-4-ylacetamides as A2A receptor antagonists: 2. Reduction of hERG activity, observed species selectivity, and structure-activity relationships.",J. Med. Chem.,2008.0,51.0,6.0,"Slee DH, Moorjani M, Zhang X, Lin E, Lanier MC, Chen Y, Rueter JK, Lechner SM, Markison S, Malany S, Joswig T, Santos M, Gross RS, Williams JP, Castro-Palomino JC, Crespo MI, Prat M, Gual S, Díaz JL, Jalali K, Sai Y, Zuo Z, Yang C, Wen J, O'Brien Z, Petroski R, Saunders J",,465697.0,DTCT0023241,2321273,DTCC00113109,1151792,25415,6.187086643357144,CC1=CC=C(O1)C2=NC(=CC(=N2)N3C(=CC(=N3)C)C)NC(=O)CCN(C)C,Cc1cc(C)n(-c2cc(NC(=O)CCN(C)C)nc(-c3ccc(C)o3)n2)n1
14565,CHEMBL446446,Q12809,,ABIVOOWWGYJNLV-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,16335928.0,INHIBITION,=,10.0,%,,cell_based,,,,,,,,,,,CHO,Percentage inhibitory activity against hERG potassium channel transfected in CHO cells at 10uM,,Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1.,J. Med. Chem.,2005.0,48.0,25.0,"Napper AD, Hixon J, McDonagh T, Keavey K, Pons JF, Barker J, Yau WT, Amouzegh P, Flegg A, Hamelin E, Thomas RJ, Kates M, Jones S, Navia MA, Saunders JO, DiStefano PS, Curtis R",,325289.0,DTCT0023241,1867180,DTCC00408775,1209402,19992,10.0,C1CCC2=C(C(C1)C(=O)N)NC3=C2C=C(C=C3)Cl,NC(=O)C1CCCCc2c1[nH]c1ccc(Cl)cc21
14691,CHEMBL456654,Q12809,,ABAOWFCFAADMKA-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,18954985.0,IC50,>,30000.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of human ERG expressed in CHO cells,,"Novel 3,3-disubstituted pyrrolidines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008.0,18.0,23.0,"Bannwart LM, Carter DS, Cai HY, Choy JC, Greenhouse R, Jaime-Figueroa S, Iyer PS, Lin CJ, Lee EK, Lucas MC, Lynch SM, Madera AM, Moore A, Ozboya K, Raptova L, Roetz R, Schoenfeld RC, Stein KA, Steiner S, Villa M, Weikert RJ, Zhai Y",,493421.0,DTCT0023241,2602852,DTCC00564544,240800,32656,4.522878745280337,C1CNCC1(CC2=CC=CC=N2)C3=CC4=C(C=C3)NC=C4,c1ccc(CC2(c3ccc4[nH]ccc4c3)CCNC2)nc1
15282,CHEMBL488069,Q12809,,AAQZZAVVFRIEOD-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,18948001.0,IC50,=,1120.0,NM,,,,,,,,,,,,,,Displacement of [3H]dofetilide from human ERG channel,,"Quantitative structure-activity relationship of phenoxyphenyl-methanamine compounds with 5HT2A, SERT, and hERG activities.",Bioorg. Med. Chem. Lett.,2008.0,18.0,23.0,"Mente S, Gallaschun R, Schmidt A, Lebel L, Vanase-Frawley M, Fliri A",,558175.0,DTCT0023241,2789569,DTCC00514128,694186,31612,5.950781977329818,CN(C)CC1=C(C=C(C=C1)C(F)(F)F)OC2=CC(=C(C=C2)Cl)Cl,CN(C)Cc1ccc(C(F)(F)F)cc1Oc1ccc(Cl)c(Cl)c1
15326,CHEMBL490153,Q12809,A-867744,ABACVOXFUHDKNZ-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,19419141.0,IC50,>,20000.0,NM,,,,,,,,,,,,,,Inhibition of human ERG channel,,Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2009.0,52.0,10.0,"Faghih R, Gopalakrishnan SM, Gronlien JH, Malysz J, Briggs CA, Wetterstrand C, Ween H, Curtis MP, Sarris KA, Gfesser GA, El-Kouhen R, Robb HM, Radek RJ, Marsh KC, Bunnelle WH, Gopalakrishnan M",,498653.0,DTCT0023241,2715764,DTCC00005756,2080159,34100,4.698970004336019,CCC(=O)C1=C(N(C(=C1)C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)S(=O)(=O)N)C,CCC(=O)c1cc(-c2ccc(Cl)cc2)n(-c2ccc(S(N)(=O)=O)cc2)c1C
15327,CHEMBL490153,Q12809,A-867744,ABACVOXFUHDKNZ-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,19419141.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]dofetilide from human ERG channel,,Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor.,J. Med. Chem.,2009.0,52.0,10.0,"Faghih R, Gopalakrishnan SM, Gronlien JH, Malysz J, Briggs CA, Wetterstrand C, Ween H, Curtis MP, Sarris KA, Gfesser GA, El-Kouhen R, Robb HM, Radek RJ, Marsh KC, Bunnelle WH, Gopalakrishnan M",,498652.0,DTCT0023241,2715763,DTCC00005756,2080159,34100,5.0,CCC(=O)C1=C(N(C(=C1)C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)S(=O)(=O)N)C,CCC(=O)c1cc(-c2ccc(Cl)cc2)n(-c2ccc(S(N)(=O)=O)cc2)c1C
16114,CHEMBL538635,Q12809,,ABRIRNSRFVVIJK-KIHHCIJBSA-N,0,HERG,KCNH2,Ion channel,,,19663444.0,INHIBITION,=,4.0,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of human ERG potassium channel expressed in CHO-K1 cells at 3 uM by whole cell voltage clamp assay,,A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.,J. Med. Chem.,2009.0,52.0,17.0,"McKinnell RM, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Goldblum A, Humphrey PP, Long DD, Marquess DG, Shaw JP, Smith JA, Turner SD, Vickery RG",,583014.0,DTCT0023241,2900934,DTCC00585340,1789196,35289,4.0,CC(C)N1C2=CC=CC=C2C=C(C1=O)C(=O)NC3C[C@H]4CC[C@@H](C3)N4C[C@H](CN5CCN(CC5)S(=O)(=O)C)O,CC(C)n1c(=O)c(C(=O)NC2C[C@@H]3CC[C@H](C2)N3C[C@@H](O)CN2CCN(S(C)(=O)=O)CC2)cc2ccccc21
16115,CHEMBL538635,Q12809,,ABRIRNSRFVVIJK-KIHHCIJBSA-N,0,HERG,KCNH2,Ion channel,,,22683222.0,INHIBITION,=,4.0,%,,cell_based,,,,,,,,,,,CHO,Inhibition of human ERG expressed in CHO cells at 3 uM,,"Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: clinical compound TD-2749.",Bioorg. Med. Chem. Lett.,2012.0,22.0,14.0,"Long DD, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Goldblum AA, Humphrey PP, Marquess DG, Shaw JP, Smith JA, Derek Turner S, Vickery RG",,829300.0,DTCT0023241,10537632,DTCC00585340,1779824,48889,4.0,CC(C)N1C2=CC=CC=C2C=C(C1=O)C(=O)NC3C[C@H]4CC[C@@H](C3)N4C[C@H](CN5CCN(CC5)S(=O)(=O)C)O,CC(C)n1c(=O)c(C(=O)NC2C[C@@H]3CC[C@H](C2)N3C[C@@H](O)CN2CCN(S(C)(=O)=O)CC2)cc2ccccc21
16116,CHEMBL538635,Q12809,,ABRIRNSRFVVIJK-KIHHCIJBSA-N,0,HERG,KCNH2,Ion channel,,,22959244.0,INHIBITION,=,4.0,%,,cell_based,,,,,,,,,,,CHO,Inhibition of human ERG expressed in CHO cells at 3 uM,,"Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Long DD, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Genov D, Goldblum AA, Humphrey PP, Jiang L, Marquess DG, Shaw JP, Smith JA, Turner SD, Vickery RG",,841622.0,DTCT0023241,10607080,DTCC00585340,1799654,49752,4.0,CC(C)N1C2=CC=CC=C2C=C(C1=O)C(=O)NC3C[C@H]4CC[C@@H](C3)N4C[C@H](CN5CCN(CC5)S(=O)(=O)C)O,CC(C)n1c(=O)c(C(=O)NC2C[C@@H]3CC[C@H](C2)N3C[C@@H](O)CN2CCN(S(C)(=O)=O)CC2)cc2ccccc21
16124,CHEMBL538956,Q12809,,ABBXOBHUMXCOGM-PKQPGRETSA-N,0,HERG,KCNH2,Ion channel,,,19663444.0,INHIBITION,=,87.0,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of human ERG potassium channel expressed in CHO-K1 cells at 3 uM by whole cell voltage clamp assay,,A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.,J. Med. Chem.,2009.0,52.0,17.0,"McKinnell RM, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Goldblum A, Humphrey PP, Long DD, Marquess DG, Shaw JP, Smith JA, Turner SD, Vickery RG",,583014.0,DTCT0023241,2900881,DTCC00593152,1407093,35289,87.0,CCOC(=O)N1CCN(CC1)CCCCCCCN2[C@@H]3CC[C@H]2CC(C3)NC(=O)C4=CC5=CC=CC=C5N(C4=O)C(C)C,CCOC(=O)N1CCN(CCCCCCCN2[C@H]3CC[C@@H]2CC(NC(=O)c2cc4ccccc4n(C(C)C)c2=O)C3)CC1
16193,CHEMBL541968,Q12809,,ABRIRNSRFVVIJK-UEQSERJNSA-N,0,HERG,KCNH2,Ion channel,,,19663444.0,INHIBITION,=,6.0,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of human ERG potassium channel expressed in CHO-K1 cells at 3 uM by whole cell voltage clamp assay,,A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.,J. Med. Chem.,2009.0,52.0,17.0,"McKinnell RM, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Goldblum A, Humphrey PP, Long DD, Marquess DG, Shaw JP, Smith JA, Turner SD, Vickery RG",,583014.0,DTCT0023241,2900933,DTCC00586855,468755,35289,6.0,CC(C)N1C2=CC=CC=C2C=C(C1=O)C(=O)NC3C[C@H]4CC[C@@H](C3)N4C[C@@H](CN5CCN(CC5)S(=O)(=O)C)O,CC(C)n1c(=O)c(C(=O)NC2C[C@@H]3CC[C@H](C2)N3C[C@H](O)CN2CCN(S(C)(=O)=O)CC2)cc2ccccc21
16455,CHEMBL553395,Q12809,,ABYFXYVIEFXQPH-HNNXBMFYSA-N,0,HERG,KCNH2,Ion channel,,,19616432.0,IC50,=,2270.0,NM,,,,,,,,,,,,,,Displacement of [3H]dofetilide from human ERG,,"Design, synthesis and evaluation of N-[(3S)-pyrrolidin-3-yl]benzamides as selective noradrenaline reuptake inhibitors: CNS penetration in a more polar template.",Bioorg. Med. Chem. Lett.,2009.0,19.0,16.0,"Fish PV, Wakenhut F, Ryckmans T, Stobie A",,581596.0,DTCT0023241,2912810,DTCC00585231,295200,35247,5.6439741428068775,CSC1=CC=CC=C1C(=O)N([C@H]2CCNC2)C3CCCCC3,CSc1ccccc1C(=O)N(C1CCCCC1)[C@H]1CCNC1
16457,CHEMBL553405,Q12809,,ABRIRNSRFVVIJK-ACDIJKPMSA-N,0,HERG,KCNH2,Ion channel,,,19663444.0,INHIBITION,=,10.0,%,,cell_based,,,,,,,,,,,CHO-K1,Inhibition of human ERG potassium channel expressed in CHO-K1 cells at 3 uM by whole cell voltage clamp assay,,A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.,J. Med. Chem.,2009.0,52.0,17.0,"McKinnell RM, Armstrong SR, Beattie DT, Choi SK, Fatheree PR, Gendron RA, Goldblum A, Humphrey PP, Long DD, Marquess DG, Shaw JP, Smith JA, Turner SD, Vickery RG",,583014.0,DTCT0023241,2900932,DTCC00594800,1148065,35289,10.0,CC(C)N1C2=CC=CC=C2C=C(C1=O)C(=O)NC3C[C@H]4CC[C@@H](C3)N4CC(CN5CCN(CC5)S(=O)(=O)C)O,CC(C)n1c(=O)c(C(=O)NC2C[C@@H]3CC[C@H](C2)N3CC(O)CN2CCN(S(C)(=O)=O)CC2)cc2ccccc21
16730,CHEMBL561446,Q12809,,AAICVIMODTZYOT-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,19469546.0,INHIBITION,=,5.0,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human ERG expressed in HEK293 cells assessed as blockade of KCl-stimulated depolarization relative to terfenadine,,Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.,J. Med. Chem.,2009.0,52.0,13.0,"Hwang JY, Arnold LA, Zhu F, Kosinski A, Mangano TJ, Setola V, Roth BL, Guy RK",,577231.0,DTCT0023241,2877872,DTCC00583043,1621465,34677,5.0,CCCCCCS(=O)(=O)C1=CC(=C(C(=C1)Cl)C(=O)CCN(C)C)Cl,CCCCCCS(=O)(=O)c1cc(Cl)c(C(=O)CCN(C)C)c(Cl)c1
16890,CHEMBL564347,Q12809,,ABSKTFYOWZQKEU-LBEPJEHYSA-N,0,HERG,KCNH2,Ion channel,,,19560918.0,IC50,=,6309.57,NM,,,,,,,,,,,,,,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay,,Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identification.,Bioorg. Med. Chem. Lett.,2009.0,19.0,16.0,"Holmes IP, Micheli F, Gaines S, Lorthioir O, Watson SP, Fabio RD, Gentile G, Heidbreder C, Savoia C, Worby A",,582205.0,DTCT0023241,2912307,DTCC00585071,468736,35180,5.200000237109354,CC1(C2CCC1(CC2)CN(C)CCN3CCN(C3=O)C4=CC5=C(C=C4)OCO5)C,CN(CCN1CCN(c2ccc3c(c2)OCO3)C1=O)CC12CCC(CC1)C2(C)C
17132,CHEMBL572238,Q12809,,AAESUDNQMFKPOQ-UHFFFAOYSA-N,0,HERG,KCNH2,Ion channel,,,19648007.0,IP,=,154.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [35S]MK499 from human ERG expressed in HEK293 cells,,Synthesis and evaluation of novel tricyclic benzo[4.5]cyclohepta[1.2]pyridine derivatives as NMDA/NR2B antagonists.,Bioorg. Med. Chem. Lett.,2009.0,19.0,17.0,"McIntyre CJ, McCauley JA, Bednar B, Bednar RA, Butcher JW, Claremon DA, Cunningham ME, Freidinger RM, Gaul SL, Homnick CF, Koblan KS, Mosser SD, Romano JJ, Liverton NJ",,599714.0,DTCT0023241,3113994,DTCC00604231,1906996,36146,6.812479279163537,C1CC2=C(CC3=C1C(=CC=C3)C#N)C=C(C=N2)C4=CC=CC=C4,N#Cc1cccc2c1CCc1ncc(-c3ccccc3)cc1C2
17950,CHEMBL605,Q12809,PROCAINAMIDE HYDROCHLORIDE,ABTXGJFUQRCPNH-UHFFFAOYSA-N,4,HERG,KCNH2,Ion channel,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity. (Class of assay: confirmatory) ,inconclusive,PUBCHEM BIOASSAY DATA SET,,,,,,,752583.0,DTCT0023241,6703168,DTCC00103812,1121521,33038,4.650000220873455,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl,CCN(CC)CCNC(=O)c1ccc(N)cc1
18679,CHEMBL990,Q12809,BUTENAFINE,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,4,HERG,KCNH2,Ion channel,,,,IC50,,,,,,,,,,,,,,,,HEK293,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774669.0,DTCT0023241,7273159,DTCC00218762,1862713,46191,,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32,CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12
18680,CHEMBL990,Q12809,BUTENAFINE,ABJKWBDEJIDSJZ-UHFFFAOYSA-N,4,HERG,KCNH2,Ion channel,,,,KI,,,,,,,,,,,,,,,,HEK293,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774669.0,DTCT0023241,7273160,DTCC00218762,1862713,46191,,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32,CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12
